424B3 1 abwn_424b3.htm 422B3 abwn_424b3.htm

Filed Pursuant to Rule 424(b)(3)

File No. 333-220295

Prospectus Supplement No. 3

(To Prospectus dated May 23, 2018)

 

8,000 Units, Each Consisting of One Share of Series A Convertible Preferred Stock and Series 1 Warrant to Purchase one share of Series A Convertible Preferred Stock, Series 2 Warrant to purchase one share of Series A Convertible Preferred Stock and Series 3 Warrant to Purchase one Share of Series A Convertible Preferred Stock

 

 

This prospectus supplement updates, amends and supplements the prospectus dated May 23, 2018 , as updated, amended and supplemented by the prospectus supplements dated July 10, 2018 and August 28, 2018 (collectively, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration No. 333-220295). Capitalized terms used in this prospectus supplement and not otherwise defined herein have the meanings specified in the Prospectus. This prospectus supplement is being filed to update, amend and supplement the information included in the Prospectus to disclose that the Company and the warrant holders have agreed to (i) extend the expiration date of the Series 1 Warrants from November 29, 2018 to May 29, 2019 and (ii) extend the expiration date of the Series 2 Warrants from November 29, 2018 to May 29, 2019.

 

This prospectus supplement is not complete without the Prospectus. This prospectus supplement should be read in conjunction with the Prospectus, which is to be delivered with this prospectus supplement, and is qualified by reference thereto, except to the extent that the information in this prospectus supplement updates or supersedes the information contained in the Prospectus. Please keep this prospectus supplement with your Prospectus for future reference.

 

Our common stock is currently quoted on the OTC Pink under the symbol “ABWN.” On October 16, 2018, the last reported per share price for our common stock was $0.0017, as quoted by the OTC Pink. There is no established trading market for the Series A Convertible Preferred Stock or the Warrants, and we do not intend to list the Series A Convertible Preferred Stock or the Warrants on any national securities exchange.

 

Investing in our securities involves significant risks. See “Risk Factors” beginning on page 7 of the prospectus for a discussion of information that should be considered before investing in our securities.

 

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved the securities described herein or determined if this prospectus supplement or the prospectus is truthful or complete. Any representation to the contrary is a criminal offense. The securities are not being offered in any jurisdiction where the offer is not permitted.

 

The date of this prospectus supplement is October 17, 2018